SCHEMBL9317593

SCHEMBL9317593

CC(C)(c1ccccc1)c1ccc(Cl)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.60
ESR2 Q92731 4/20 0.60
ALDH1A1 P00352 2/20 0.60
CYP3A4 P08684 2/20 0.60
CNR1 P21554 2/20 0.53
CNR2 P34972 2/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
CYP19A1 P11511 1/20 0.48
TSHR P16473 2/20 0.48
NR3C2 P08235 3/20 0.47
KIF11 P52732 1/20 0.47
CYP1A2 P05177 1/20 0.46
BCL2 P10415 1/20 0.44
ALOX15 P16050 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
SLC6A2 P23975 2/20 0.44
SLC6A4 P31645 2/20 0.44
SLC6A3 Q01959 2/20 0.44
AR P10275 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2768675 0.89 MEN1 (0.62) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL31497682 0.89 MEN1 (0.62) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL7535051 0.87 ESR1 (0.75) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL25039218 0.85 KMT2A (0.52) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL10838797 0.85 CYP19A1 (0.64) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL35881 0.84 ESR1 (0.70) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL14910456 0.84 ESR1 (0.70) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL11579850 0.83 SMN1; SMN2 (0.45) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL4062666 0.81 KMT2A (0.82) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL16144309 0.81 KMT2A (0.82) ESR1ESR2ALDH1A1CYP3A4CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025073702-A1 PROCESS FOR PREPARING AROMATIC AMINES FROM ARYL CHLORIDES BASF SE (DE) 2025-04-10 WO disclosed
US-9434705-B2 L-setastine hydrochloride and preparation method thereof ANHUI QINGYUN PHARMACEUTICAL & CHEMICAL CO., LTD. (CN) 2016-09-06 US disclosed
US-20140296517-A1 L-Setastine Hydrochloride and Preparation Method Thereof ANHUI QINGYUN PHARMACEUTICAL 2014-10-02 US disclosed
US-5288848-A Reacting mono- and dihalogenated aromatics with alkali sulfide ; low corrosion during processing BAYER AKTIENGESELLSCHAFT (DE) 1994-02-22 US disclosed
US-4929747-A POLYMERIZATION CATALYSTS NIPPON OIL & FATS COMPANY, LTD. (JP) 1990-05-29 US disclosed
US-4760127-A Reacting dihalogen aromatics and alkali metal sulfide in presence of a monohalogen compound and a monomercapto compound BAYER AG (DE) 1988-07-26 US disclosed
EP-0214471-A1 Process for the preparation of high molecular weight polyarylene sulfides which can be reticulated BAYER AG (DE) 1987-03-18 EP disclosed
US-3989611-A HALOGENATED HYDROCARBON CATALYST THE FIRESTONE TIRE & RUBBER COMPANY (US) 1976-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296517-A1 L-Setastine Hydrochloride and Preparation Method Thereof HRH4, HRH1, HRH3 ESR1 2122/4885ESR2 2715/4885ALDH1A1 2924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.